Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ...Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...


JACKI AND BRUCE BARRON CANCER RESEARCH SCHOLARS' PROGRAM SYMPOSIUM

The Jacki and Bruce Barron Cancer Research Scholars' Program, a partnership between ICRF and City of Hope, is generously supported by The Harvey L. Miller Family Foundation of Chicago. This program was established to foster collaborative research and promote the exchange of ideas between exceptional researchers in the United States and Israel. Through this joint program, teams of investigators are advancing our understanding of cancer in order to develop life-saving therapies, novel diagnostic approaches and preventative strategies.

The topics of research span from the underlying mechanisms of cancer initiation and progression, to targeted therapies of specific cancer types, to the role of microbes in resistance to anti-cancer therapies. 
The second annual symposium took place at Jerusalem's Hadassah Hospital in November 2018, where scientists presented their findings to other researchers and ICRF supporters.

Key Highlights:

  • Dr. Dan Raz (City of Hope) and Dr. Ravid Straussman (Weizmann), whose work is at the leading edge of microbiome research, identified specific bacteria that contribute to drug resistance in lung cancer;
  • Dr. Markus Müschen (City of Hope) and Dr. Shai Izraeli (Tel Aviv University) whose work is focused on B-cell leukemia, the most frequent type of cancer in children and young adults, are testing strategies to kill cancer stem cells in order to prevent cancer-recurrence and reduce the side-effects of chemotherapy.
  • Dr. Jeffrey Weitzel (City of Hope) and Dr. Gad Rennert (Carmel Medical Center) are exploring a variety of genetic mutations to determine which are most significantly associated with increased risk of breast cancer in young women.